Area of research
Molecular Biology · Hematology
Research interest
Research interests include Inflammasome and immune disorders, Autoimmune and Inflammatory Disorders Research, Vasculitis and related conditions, and Systemic Lupus Erythematosus Research.
TGFβ links EBV to multisystem inflammatory syndrome in children
Unfolding dermatological spectrum of Still’s disease: a cohort study from the International AIDA Network Still’s Disease Registry
EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease
Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project
Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study
Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis
Interleukin (IL)-1/IL-6-Inhibitor–Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses
Mevalonate kinase deficiency: an updated clinical overview and revision of the SHARE recommendations
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders
Evaluation and Management of Deficiency of Adenosine Deaminase 2
Feasibility of Conducting Comparative Effectiveness Research and Validation of a Clinical Disease Activity Score for Chronic Nonbacterial Osteomyelitis
A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project
The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, and deficiency of the interleukin-1 receptor antagonist
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS
Human OTULIN haploinsufficiency impairs cell-intrinsic immunity to staphylococcal α-toxin
The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: <scp>CANDLE</scp>/<scp>PRAAS</scp>, <scp>SAVI</scp>, and <scp>AGS</scp>
Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients
International Consensus for the Dosing of Corticosteroids in <scp>Childhood‐Onset</scp> Systemic Lupus Erythematosus With Proliferative Lupus Nephritis
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial
Classification criteria for autoinflammatory recurrent fevers
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
<i>IL1RN</i> Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin‐1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis
Towards a new set of classification criteria for PFAPA syndrome
The European network for care of children with paediatric rheumatic diseases: care across borders
An International Delphi Survey for the Definition of New Classification Criteria for Familial Mediterranean Fever, Mevalonate Kinase Deficiency, TNF Receptor–associated Periodic Fever Syndromes, and Cryopyrin-associated Periodic Syndrome
Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal Lesions
Blau Syndrome–Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series
Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome